Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 16, 2022; 10(26): 9484-9492
Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9484
Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9484
Postoperative radiotherapy for thymus salivary gland carcinoma: A case report
Rui Deng, Liang-Liang Bai, Yong-Sheng Wang, Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Department of Thoracic Oncology, West China Hospital, Sichuan University, Cheng Du 610041, Sichuan Province, China
Nan-Jing Li, Shi-Hong Nie, Xiao-Wen Sun, Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Cheng Du 610041, Sichuan Province, China
Author contributions: Deng R and Li NJ contributed equally to this work; all authors have read and approve the final manuscript.
Informed consent statement: This study involving human participant was approved by the Ethics Committee of the West China Hospital of Sichuan University. Written informed consent was obtained from the patient for the publication of all images and data included in this article.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yong-Sheng Wang, PhD, Chief Doctor, Professor, Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Wuhou District, Cheng Du 610041, Sichuan Province, China. wangys75@gmail.com
Received: May 6, 2022
Peer-review started: May 6, 2022
First decision: May 31, 2022
Revised: June 12, 2022
Accepted: August 1, 2022
Article in press: August 1, 2022
Published online: September 16, 2022
Processing time: 119 Days and 2.4 Hours
Peer-review started: May 6, 2022
First decision: May 31, 2022
Revised: June 12, 2022
Accepted: August 1, 2022
Article in press: August 1, 2022
Published online: September 16, 2022
Processing time: 119 Days and 2.4 Hours
Core Tip
Core Tip: In this report, we showed one one 33-year-old middle-aged man presented with a thymus mass without any clinical symptoms when he underwent regular physical examination. After completing the pre-operative examinations, it was confirmed that the patient had indications for surgery. The surgeon performed a transthoracoscope "thymectomy + pleural mucostomy" for him. The final pathological result suggested: Thymus salivary gland carcinoma-mucoepidermoid carcinoma, which was rarely reported in literatures. The patient underwent a local radiotherapy for total dose of 50.4 Gy after the surgery. He had no sign of recurrence and continued to survive as of time of publication.